GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: compound 24 [WO2020214734A1] | VT-3989
Compound class:
Synthetic organic
Comment: VT3989 is an orally bioavailable YAP/TAZ inhibitor that is proposed for antineoplastic potential. The structure is claimed in Vivace Therapeutics' patent WO2020214734A1 [2]. VT3989 inhibits YAP function and subsequent TEAD palmitoylation that would otherwise drive activation of transcriptional enhancer associate domain (TEAD) transcription factors that promote cell proliferation [3]. Hyperactivation of the Hippo-YAP/TAZ-TEAD pathway is implicated in tumour progression [1].
|
|
Bioactivity Comments |
Inhibits YAP-mediated transcriptional activity with IC50 <100 nM [2]. |